Back to Search
TILLMANN CYRUS, MD
MD
Cardiovascular Disease Physician
NPI: 1598970352Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
2004010829(MO)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
2004010829(MO)
Research & Publications (20)
Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.
PMID 18292395·Arterioscler Thromb Vasc Biol·2008
7-preclinical
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.
PMID 17306791·Eur J Pharmacol·2007
7-preclinical
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin.
PMID 16326168·Atherosclerosis·2006
4-observational
Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
PMID 16076280·Expert Rev Cardiovasc Ther·2005
6-review
Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.
PMID 19220291·Br J Pharmacol·2009
7-preclinical
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
PMID 17365236·J Cardiovasc Magn Reson·2007
7-preclinical
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
PMID 18203420·Int J Nanomedicine·2007
6-review
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice.
PMID 17158227·Blood·2007
7-preclinical
Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
PMID 17716162·Nanomedicine (Lond)·2006
6-review
MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.
PMID 16755843·J Cardiovasc Magn Reson·2006
7-preclinical
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice.
PMID 16267259·Circulation·2005
7-preclinical
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions.
PMID 12566360·Circulation·2003
7-preclinical
Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice.
PMID 12208806·Circulation·2002
7-preclinical
Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia.
PMID 12122008·J Biol Chem·2002
7-preclinical
Reaction to videocolposcopy in the assessment of child sexual abuse.
PMID 11766015·Child Abuse Negl·2001
8-other
Lipid peroxidation and platelet activation in murine atherosclerosis.
PMID 11602498·Circulation·2001
7-preclinical
12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice.
PMID 11581143·Circulation·2001
7-preclinical
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
PMID 11342477·Circulation·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 HOSPITAL DR
COLUMBIA, MO 65201 - Phone
- (573) 882-2296
Quick Facts
- NPI
- 1598970352
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile